Viatris topped analysts’ estimates for first-quarter revenue and profit on Thursday, buoyed by strength in its China business and strong demand for branded drugs.
Shares of the company were up over 3% in afternoon trading following the results.
Sign up here.
The drugmaker has been under pressure from manufacturing issues and generic-drug competition, prompting investors to watch whether its base business and … [1763 chars]
Source: Reuters | Published: 2026-05-07T16:30:07Z
Credit: Reuters
